Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -30.71%872.26M | -36.86%943.73M | -47.78%770.7M | 21.03%5.29B | -23.09%1.06B | 16.62%1.26B | 58.54%1.49B | 52.53%1.48B | -1.81%4.37B | -18.98%1.38B |
| Cost of revenue | -37.00%547.47M | -32.83%561.95M | -57.05%489.2M | 15.17%3.49B | -28.97%647.92M | 10.33%869.06M | 32.49%836.59M | 62.45%1.14B | -10.53%3.03B | -33.20%912.15M |
| Gross profit | -16.67%324.79M | -41.98%381.78M | -16.49%281.49M | 34.28%1.8B | -11.73%416.33M | 33.60%389.74M | 111.37%657.97M | 26.43%337.08M | 25.91%1.34B | 37.75%471.66M |
| Operating expense | 9.89%55.58M | 16.60%71.15M | -20.08%46.19M | 1.36%546.97M | -35.68%67.37M | -6.42%50.58M | 1.40%61.02M | -47.46%57.8M | 23.22%539.65M | -23.49%104.74M |
| Selling and administrative expenses | 1.49%118.04M | 0.91%132.63M | -9.49%107.7M | 1.36%546.97M | 0.46%180.22M | 1.32%116.31M | 8.32%131.44M | 8.17%118.99M | 23.22%539.65M | 31.04%179.4M |
| -Selling and marketing expense | -24.42%6.85M | -12.08%7.02M | -30.05%8.92M | -30.84%43.93M | -38.91%14.13M | -28.07%9.06M | -42.34%7.98M | -8.55%12.76M | 7.34%63.52M | 15.47%23.13M |
| -General and administrative expense | 3.68%111.2M | 1.75%125.62M | -7.02%98.78M | 5.65%503.03M | 6.29%166.09M | 4.94%107.25M | 14.84%123.46M | 10.60%106.24M | 25.70%476.12M | 33.71%156.26M |
| Total other operating income | -4.97%62.46M | -12.69%61.49M | 0.51%61.51M | ---- | 51.16%112.86M | 8.20%65.73M | 15.13%70.42M | --61.19M | ---- | --74.66M |
| Operating profit | -20.63%269.21M | -47.96%310.63M | -15.75%235.3M | 56.45%1.25B | -4.90%348.96M | 42.70%339.16M | 137.73%596.95M | 78.33%279.28M | 27.78%801.65M | 78.55%366.93M |
| Net non-operating interest income (expenses) | 20.52%-80.51M | 4.49%-80.16M | 1.54%-85.85M | -16.57%-292.67M | -34.10%-111.73M | -6.32%-101.3M | 10.81%-83.93M | -14.14%-87.19M | -37.60%-251.07M | -1.17%-83.32M |
| Non-operating interest income | ---- | ---- | ---- | -6.66%91.48M | ---- | ---- | ---- | ---- | 25.75%98.01M | ---- |
| Non-operating interest expense | -20.52%80.51M | -4.49%80.16M | -1.54%85.85M | 10.86%376.27M | 34.10%111.73M | 6.32%101.3M | -10.81%83.93M | 14.14%87.19M | 34.48%339.42M | 1.17%83.32M |
| Total other finance cost | ---- | ---- | ---- | -18.51%7.87M | ---- | ---- | ---- | ---- | 20.47%9.66M | ---- |
| Net investment income | -132.70%-6.34M | 129.78%2.85M | -17.22%4.81M | 546.00%15.41M | 46.78%-4.04M | 139.89%19.38M | 44.19%-9.57M | 17.33%5.81M | -94.84%2.39M | -351.54%-7.59M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 42.51%-29.84M | 59.49%-37.66M | 23.41%-12.8M | -172.63%-126.22M | 345.50%35.36M | -251.85%-51.91M | -369.94%-92.97M | 15.19%-16.71M | -119.09%-46.3M | -24.47%7.94M |
| Special income (charges) | 6,326.57%109.83M | 197.74%1.71M | ||||||||
| Less:Other special charges | ---- | ---- | ---- | -6,326.57%-109.83M | ---- | ---- | ---- | ---- | -197.74%-1.71M | ---- |
| Other non-operating income (expenses) | 8.48M | 9.55%161.41M | 56.35M | 21.21%61.19M | 67.29%147.34M | |||||
| Income before tax | -21.60%160.99M | -58.09%195.67M | -21.93%141.47M | 71.10%1.12B | -5.42%268.56M | 51.29%205.34M | 288.77%466.83M | 56.26%181.2M | 17.38%655.72M | 50.54%283.96M |
| Income tax | -30.23%62.42M | -52.39%74.53M | -40.33%52.11M | 64.51%491.25M | 42.54%157.9M | 22.82%89.47M | 152.66%156.54M | 64.71%87.34M | 49.30%298.61M | 22.21%110.78M |
| Net income | -14.93%98.58M | -60.96%121.14M | -4.80%89.36M | 76.60%630.68M | -36.10%110.66M | 84.27%115.88M | 433.88%310.29M | 49.15%93.86M | -0.42%357.11M | 76.75%173.18M |
| Net income continuous operations | -14.93%98.58M | -60.96%121.14M | -4.80%89.36M | 76.60%630.68M | -36.10%110.66M | 84.27%115.88M | 433.88%310.29M | 49.15%93.86M | -0.42%357.11M | 76.75%173.18M |
| Noncontrolling interests | 92.65%30.54M | 39.90%21.34M | 35.09%22.34M | -6.52%54.72M | -71.60%7.08M | 43.34%15.86M | 1.31%15.25M | 120.94%16.53M | 7.98%58.54M | 119.67%24.94M |
| Net income attributable to the company | -31.98%68.03M | -66.17%99.8M | -13.33%67.02M | 92.90%575.95M | -30.13%103.57M | 93.01%100.02M | 585.10%295.03M | 39.46%77.33M | -1.92%298.57M | 71.12%148.24M |
| Preferred stock dividends | -7.09%40.9M | 0 | -22.50%40.9M | -4.60%96.79M | 0 | -27.63%44.02M | 0 | 29.86%52.77M | -37.71%101.45M | 0 |
| Other under preferred stock dividend | 0 | -1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -51.55%27.14M | -66.17%99.8M | 6.39%26.12M | 143.08%479.17M | -30.13%103.57M | 722.61%56M | 585.10%295.03M | 65.77%24.55M | 39.27%197.12M | 165.63%148.24M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -53.45%0.0054 | -68.41%0.0199 | -7.14%0.0052 | 111.67%0.1016 | -40.79%0.0209 | 627.27%0.0116 | 494.34%0.063 | 55.56%0.0056 | 37.93%0.048 | 157.66%0.0353 |
| Diluted earnings per share | -51.40%0.0052 | -66.67%0.019 | 6.38%0.005 | 100.63%0.0963 | -43.63%0.0199 | 586.36%0.0107 | 437.74%0.057 | 30.56%0.0047 | 38.33%0.048 | 157.66%0.0353 |
| Dividend per share | 0 | 0 | 114.93%0.0288 | -8.84%0.0134 | 0 | 0 | 0 | -8.84%0.0134 | 126.15%0.0147 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.